Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 4, 2009, Pages 1506-1514

  Balla, Murali M S ^a   Vemuganti, Geeta K ^a   Kannabiran, Chitra ^a   Honavar, Santosh G ^a   Murthy, Ramesh ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ETOPOSIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; MEMBRANE PROTEIN; PROTEIN PROX1; SYNTAXIN 1A; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VINCRISTINE; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CARRIER PROTEIN; CXCR4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; NSE1 PROTEIN, HUMAN; PROSPERO RELATED HOMEOBOX 1 PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; SYNTAXIN 1; TUMOR MARKER; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL ISOLATION; CELL SUBPOPULATION; CHILD; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; CHEMISTRY; DRUG SCREENING; GENE EXPRESSION REGULATION; INFANT; METHODOLOGY; PATHOLOGY; PRECANCER; PRESCHOOL CHILD; RETINA TUMOR;

ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PHENOTYPE; PRECANCEROUS CONDITIONS; RECEPTORS, CXCR4; RETINAL NEOPLASMS; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNTAXIN 1; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 64049103649     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2356     Document Type: Article

References (26)

1. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820-823.
2. Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol. 2004;137(1):18-23.
3. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer. 2005;5(2):91-101.
4. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441(7092):475-482.
5. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895-902.
6. Vercauteren SM, Sutherland HJ. CD133 (AC133) expression on AML cells and progenitors. Cytotherapy. 2001;3(6):449-459.
7. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-5828.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983-3988.
9. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65(13):5506-5511.
10. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A. 2006;103(30):11154-11159.
11. Mohan A, Kandalam M, Ramkumar HL, Gopal L, Krishnakumar S. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. Br J Ophthalmol. 2006;90(7):889-893.
12. Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol Vis. 2005;11:729-737.
13. Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007;13:823-832.
14. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464):645-648.
15. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64(19):7011-7021.
16. Krishnakumar S, Mallikarjuna K, Desai N, et al. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br J Ophthalmol. 2004;88(12):1521-1526.
17. Filho JP, Correa ZM, Odashiro AN, et al. Histopathological features and P-glycoprotein expression in retinoblastoma. Invest Ophthalmol Vis Sci. 2005;46(10):3478-3483.
18. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101(39):14228-14233.
19. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65(1):13-24.
20. Hofmann M, Rudy W, Zöller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 1991;51(19):5292-5297.
21. Rudy W, Hofmann M, Schwartz-Albiez R, et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 1993;53(6):1262-1268.
22. Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöller M. Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer. 1990;46(5):919-927.
23. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med. 1993;177(2):443-455.
24. Penno MB, August JT, Baylin SB, et al. Expression of CD44 in human lung tumors. Cancer Res. 1994;54(5):1381-1387.
25. Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol. 1991;11(11):5446-5453.
26. Maw MA, Corbeil D, Koch J, et al. A frameshift mutation in prominin (mouse):-like 1 causes human retinal degeneration. Hum Mol Genet. 2000;9(1):27-34.